| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827542 | Schizophrenia Research | 2011 | 7 Pages |
Abstract
AAPs may counteract some vascular health benefits of a diet high in N-3 FAs. AAP use may necessitate a higher N-3 FA dose to regain these effects, but additional research is necessary to strengthen the preliminary findings. Pharmacogenetic variants related to folate and homocysteine metabolism may also increase endothelial dysfunction risk.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Vicki L. Ellingrod, Stephan F. Taylor, Robert D. Brook, Simon J. Evans, Sebastian K. Zöllner, Tyler B. Grove, Kristen M. Gardner, Michael J. Bly, Rodica Pop-Busui, Gregory Dalack,